Sentinel node biopsy after primary chemotherapy in breast cancer: A note of caution from results of ABCSG-14

Breast Journal

Volumn 17, Issue 3, 2011, Pages 230-238

  Tausch, Christoph ^a   Steger, Gunther G ^b   Haid, Anton ^c   Jakesz, Raimund ^b   Fridrik, Michael A ^d   Reitsamer, Roland ^e   Pöstlberger, Sabine ^f   Lang, Alois ^c   Gnant, Michael ^b   Greil, Richard ^e  

^a Breast Center Zurich   (Switzerland)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Landeskrankenhaus Feldkirch   (Austria)

^d KEPLER UNIVERSITY HOSPITAL   (Austria)

^e Paracelsus Private Medical School   (Austria)

^f Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

Author keywords

false negative rate; primary chemotherapy; sensitivity; sentinel node biopsy; sequence of chemotherapy and sentinel node biopsy

Indexed keywords

DOCETAXEL; DYE; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; RADIOISOTOPE;

ADULT; AGED; ARTICLE; AUSTRIA; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PHASE 2 CLINICAL TRIAL (TOPIC); PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; EPIRUBICIN; FALSE NEGATIVE REACTIONS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TAXOIDS;

EID: 79955681324     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2011.01073.x     Document Type: Article

References (63)

1. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 7703-20. (Pubitemid 46291835)
2. Kim T, Giuliano AE, Lyman GH,. Lymphatic mapping and sentinel lymph node biopsy in early stage breast carcinoma-a metaanalysis. Cancer 2006; 106: 4-16. (Pubitemid 43033320)
3. Edwards M, Giuliano AE, Reintgen D, Tafra Lorraine, Whitworth P, for the American Society of Breast Surgeons. Revised consensus statement on guidelines for performance of sentinel lymphadenectomy for breast cancer; 2000
4. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006; 95: 279-93.
5. Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006; 7: 983-90. (Pubitemid 44804136)
6. Bonadonna G, Veronesi U, Brambilla C, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters and more. J Natl Cancer Inst 1990; 82: 1539-45. (Pubitemid 20296503)
7. Taucher S, Gnant M, Djavanmard M, et al. Neoadjuvant chemotherapy enables breast-conserving surgery in patients with very large breast cancer: preliminary results. Onkologie 1996; 19: 242-6.
8. Chen AM, Meric-Bernstam F, Hunt KK, et al. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 2004; 22: 2303-12. (Pubitemid 41115386)
9. Fisher B, Brown A, Mamounas E, Wieand S, Robidox A,. Effects of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from the NSABP Project B-18. J Clin Oncol 1997; 15: 2483-93. (Pubitemid 27289876)
10. Scholl SM, Fourquet A, Asselain B, et al. Neoadjuvant vs. adjuvant chemotherapy in premenopausal women with tumors considered too large for breast conserving surgery. Preliminary results of a randomized trial. Eur J Cancer 1994; 30A: 645-52. (Pubitemid 24164252)
11. Cunningham JD, Weiss SE, Ahmed S, et al. The efficacy of neoadjuvant chemotherapy compared to postoperative therapy in the treatment of locally advanced breast cancer. Cancer Invest 1998; 16: 80-6. (Pubitemid 28146126)
12. Greil R,. The still long and winding road to neoadjuvant systemic therapy as the standard of care in breast cancer. Breast Care 2006; 1: 352-7. (Pubitemid 46025405)
13. Bear HD, Anderson S, Brown A, et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2003; 21: 4165-74. (Pubitemid 46606185)
14. Kaufmann M, von Minckwitz G, Bear HD, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol 2007; 18: 1927-34. (Pubitemid 350286227)
15. Haid A, Tausch C, Lang A, et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast cancer? Cancer 2001; 92: 1080-4. (Pubitemid 32861654)
16. Tausch C, Konstantiniuk P, Jörg L, et al. Sentinel lymph node biopsy after preoperative chemotherapy in breast carcinoma-is it safe? Eur Surg 2002; 34: 283-7. (Pubitemid 36124688)
17. Tausch C, Konstantiniuk P, Kugler F, et al. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: Findings from the Austrian sentinel node study group. Ann Surg Oncol 2008; 15: 3378-83.
18. Steger GG, Galid A, Gnant M, et al. Pathologic complete response with 6 vs 3 cycles of neoadjuvant epirubicin/docetaxel plus G-CSF in operable breast cancer. results of ABCSG -14. J Clin Oncol 2007; 25: 2012-8. (Pubitemid 46972785)
19. Greil R, Psenak O, Roila F,. ESMO Guidelines Working Group. Hematopoietic groth factors: ESMO recommendations for the applications. Ann Oncol 2008; 19 (Suppl. 2): ii116-8.
20. Rudas M, Konstantiniuk P, Horvat R, et al. Sentinel lymph node examination: balancing between high workload and low metastasis detection rate. Eur Surg 2002; 34: 277-9. (Pubitemid 36124686)
21. Mantel N, Haenszel W,. Statistical aspects of analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
22. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN,. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006; 93: 1025-6.
23. Balch GC, Mithani SK, Richards KR, Beauchamp RD, Kelley MC,. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 2003; 10: 616-21. (Pubitemid 40486892)
24. Julian TB, Patel N, Dusi D, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2001; 182: 407-10. (Pubitemid 33079097)
25. Brady EW,. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 2002; 8: 97-100. (Pubitemid 34233588)
26. Miller AR, Thomason VE, Yeh IT, et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol 2002; 9: 243-7. (Pubitemid 34298628)
27. Kang SH, Kim SK, Kwon Y, et al. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg 2004; 28: 1019-24. (Pubitemid 40109887)
28. Fernandez A, Cortes M, Benito E, et al. Gamma probe sentinel node localisation and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Comm 2001; 22: 361-6. (Pubitemid 32291650)
29. Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27. J Clin Oncol 2005; 23: 2694-702. (Pubitemid 46179459)
30. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8: 881-8. (Pubitemid 47488052)
31. Nason KS, Anderson BO, Byrd DA, et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy. Cancer 2000; 89: 2187-93.
32. Breslin TM, Cohen L, Sahin S, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000; 18: 3480-6.
33. Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Annals of Surg 2001; 233: 51-9. (Pubitemid 32042775)
34. Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN,. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002; 9: 235-42. (Pubitemid 34298627)
35. Piato JR, Barros AC, Pincerato KM, Sampaio AP, Pinotti JA,. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 2003; 29: 118-20. (Pubitemid 36367342)
36. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E,. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 2003; 84: 63-7. (Pubitemid 37247910)
37. Tanaka Y, Maeda H, Ogawa Y, et al. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Oncol Rep 2006; 15: 927-31.
38. Le BouAdec G, Geissler B, Gimbergues P, et al. Sentinel lymph node biopsy for breast cancer after neoadjuvant chemotherapy: influence of nodal status before treatment. Bull Cancer 2006; 93: 415-9. (Pubitemid 43742491)
39. Yu JC, Hsu GC, Hsieh CB, Yu CP, Chao TY,. Role of sentinel lymphadenectomy combined with intraoperative ultrasound in the assessment of locally advanced breast cancer after neoadjuvant chemotherapy. Ann Surg Oncol 2007; 14: 174-80.
40. Péley G, Török K, Farkas E, et al. The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer]. Magy Onkol. 2006; 50: 19-23. Epub 2006 April 17
41. Kinoshita T, Takasugi M, Iwamoto E, Akashi-Tanaka S, Fukutomi T, Terui S,. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Am J Surg 2006; 191: 225-9. (Pubitemid 43151271)
42. Shen J, Gilcrease MZ, Babiera GV, et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 2007; 109: 1255-63. (Pubitemid 46466551)
43. Gimbergues P, Abrial C, Durando X, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 2008; 15: 1316-21.
44. Kuerer HM, Sahin AA, Hunt KK, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastasis before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 1999; 230: 72-8. (Pubitemid 30190367)
45. Bolat F, Kayaselcuk F, Nursal TZ, Yagmurdur MC, Bal N, Demirhan B,. Microvessel density, VEGF expression, and tumorassociated macrophages in breast tumors: correlations with prognostic parameters. J Exp Clin Cancer Res 2006; 25: 365-72. (Pubitemid 44763728)
46. Sharkey FE, Addington SL, Fowler LJ, Page CP, Cruz AB,. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 1996; 9: 893-900. (Pubitemid 26319719)
47. Aihara T, Munakata S, Morino H, Takatsuka Y,. Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study. J Surg Oncol 2004; 85: 77-81. (Pubitemid 38160774)
48. Eiermann W, Paepke S, Appfelstaedt J, et al. Letrozole Neo-Adjuvant Breast Cancer Study Group. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study. Ann Oncol 2001; 12: 1527-32. (Pubitemid 34065880)
49. Smith IE, Dowsett M, Ebbs SR, et al. IMPACT Trialists Group. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. J Clin Oncol 2005; 23: 5108-16. (Pubitemid 46224019)
50. Martin RC II, Chagpar A, Scoggins CR, et al. University of Louisville Breast Cancer Sentinel Lymph Node Study. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 2005; 241: 1005-12; discussion 1012-5
51. Lang JE, Esserman LJ, Ewing CA, et al. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg 2004; 199: 856-62. (Pubitemid 39536257)
52. Cox CE, Dupont E, Whitehead GF, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 2002; 8: 88-91. (Pubitemid 34233586)
53. Schrenk P, Hochreiner G, Fridrik M, Wayand W,. Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer. Breast J 2003; 9: 282-7. (Pubitemid 36927407)
54. Sabel MS, Schott AF, Kleer CG, et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg 2003; 186: 102-5. (Pubitemid 37289077)
55. Jones JL, Zabicki K, Christian RL, et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg 2005; 190: 517-20. (Pubitemid 41306067)
56. Ollila DW, Neuman HB, Sartor C, Carey LA, Klauber-Demore N,. Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers. Am J Surg 2005; 190: 371-5. (Pubitemid 41139288)
57. van Rijk MC, Nieweg OE, Rutgers EJ, et al. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol 2006; 13: 475-9.
58. O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-7. (Pubitemid 28169364)
59. Noguchi M, Motomura K, Imoto S., et al. A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 2000; 63: 31-40.
60. Olson JA Jr, Fey J, Winawer J, et al. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 2000; 191: 593-9. (Pubitemid 32004983)
61. Chung MH, Ye W, Giuliano AE,. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol 2001; 8: 688-92. (Pubitemid 32952482)
62. Wong SL, Chao C, Edwards MJ, et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am Surg 2001; 67: 522-6. (Pubitemid 33738843)
63. Bedrosian I, Reynolds C, Mick R, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000; 88: 2540-5. (Pubitemid 30331961)